|
||
|
AngioGenetics AB
Download PDF Members: AngioGenetics is a Swedish biotechnology company focusing on discovery, development, and commercialisation of novel angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. AngioGenetics has developed solid platforms for drug and target discovery, and these provide a pipeline of novel lead compounds and use-patent protected drugs to fulfil industry demands for such products.
This page has been viewed 159 times since April 2007, the link to the organisation's website has been followed 24 times Recent Search Terms used to find this page: angiogenetics ab | AngioGenetics | . Search for more companies in Gothenburg This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for AngioGenetics AB | |||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|